Morepen Laboratories Balance Sheet
- Market cap
- ₹7,216 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹94.82 – ₹177.78
As of FY25, Morepen Laboratories had total assets of ₹4,690 crore and borrowings of ₹866 crore, against shareholders' equity of ₹3,367 crore — a debt-to-equity ratio of 0.35.
Morepen Laboratories balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 3,247 |
| Borrowings | 866 |
| Other liabilities | 577 |
| Total liabilities | 4,690 |
| Fixed assets | 2,526 |
| Capital work in progress | 45 |
| Investments | 1,082 |
| Other assets | 1,082 |
| Total assets | 4,690 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹46.21
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Morepen Laboratories balance sheet — frequently asked questions
What is the total debt of Morepen Laboratories?
Morepen Laboratories reported borrowings of ₹866 crore as of FY25.
What is Morepen Laboratories' debt-to-equity ratio?
Based on the FY25 balance sheet, Morepen Laboratories' debt-to-equity ratio is 0.35 — borrowings of ₹866 crore against equity capital and reserves of ₹3,367 crore.
What are Morepen Laboratories' total assets?
Morepen Laboratories' total assets were ₹4,690 crore as of FY25, including fixed assets of ₹2,526 crore and investments of ₹1,082 crore.
What is the book value per share of Morepen Laboratories?
The book value per share of Morepen Laboratories is ₹46.21, based on the latest reported balance sheet.
Same Data For Peers
Trade Morepen Laboratories With ATS
Track MOREPENLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.